Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Solvonis Therap (SVNS) Share News

Solvonis granted US patent for AI-led CNS compound programme

23rd Jun 2025 11:12

(Alliance News) - Solvonis Therapeutics PLC on Monday said the US Patent & Trademark Office has allowed a core patent application covering compounds in its artificial-intelligence-enabled central-nervous-system discovery programme, granting protection in the US's drug market for at least 18 years. Read More

UK shareholder meetings calendar - next 7 days

20th Jun 2025 12:02

Read More

TRADING UPDATES: Ten Lifestyle celebrates new Japan contract win

11th Jun 2025 22:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Solvonis promotes Professor David Nutt to chief scientific officer

3rd Jun 2025 14:02

(Alliance News) - Solvonis Therapeutics PLC on Tuesday announced the appointment of neuroscience professor David Nutt as its chief scientific officer, with immediate effect. Read More

TRADING UPDATES: T42 IOT Tracking extends CLN repayment dates

16th May 2025 21:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

22nd Apr 2025 16:58

Read More

Solvonis shares fall with "high risk" that losses will continue

16th Apr 2025 14:05

(Alliance News) - Solvonis Therapeutics PLC said on Wednesday that it will be focusing on funding its research projects, after reporting no sources of revenue for its latest year. Read More

TRADING UPDATES: Knights Group seals buy; Kanabo position uncertain

4th Apr 2025 21:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Solvonis reports positive progress on European patent for Awakn collab

26th Mar 2025 13:43

(Alliance News) - Solvonis Therapeutics PLC on Wednesday reported "positive progress" on its European patent application for the Awkn-Sdn-14 programme. Read More

Solvonis to buy Awakn Life Sciences for around GBP5 million

24th Feb 2025 12:23

(Alliance News) - Solvonis Therapeutics PLC on Monday said it entered into an arrangement agreement to buy Toronto-based Awakn Life Sciences Corp. Read More

FTSE 100 Latest
Value8,718.75
Change-40.24